Literature DB >> 8037375

Ultrastructural, histochemical, and morphometric analysis of skeletal muscle in a murine model of type I diabetes.

K M Klueber1, J D Feczko.   

Abstract

BACKGROUND: Since peripheral nerves are damaged in diabetes mellitus, morphological changes occur within the diabetic muscle in response to the diabetic neuropathy. The aim of this study was to examine the extensor digitorum longus (EDL) from a 42-day streptozotocin-induced diabetic Swiss Webster mouse (STZ) and compare the muscle morphology and histochemistry to age-matched, nondiabetic controls.
METHODS: The EDL was evaluated using electron microscopy in order to investigate the morphological integrity of the myofibers and neuromuscular junctions. Histochemical analysis was completed using the myofibrillar CA(++)-ATPase reaction of Doriguzzi et al. (1983. Histochemistry, 79:289-294) for use in computer-assisted morphometric analysis of fiber size using Bioquant System 4 software.
RESULTS: Ultrastructural analysis of the diabetic EDL (N = 5, 225 myofibers/animal) showed a significant number of abnormal myofibers, exhibiting various degrees of degeneration, signs of denervation, and necrosis. The STZ myofibers exhibited excessive lipid accumulations and abnormal mitochondrial arrangements. Histochemical analysis of the STZ EDL revealed a significant shift in fiber type profile (53.6% type 2A and 46.4% type 2B- STZ myofibers; 47.5% type 2A, 52.5% type 2B nondiabetic controls). Morphometric analysis of myofiber size by fiber type (200 myofibers/muscle/fiber type) indicated a significant decrease in myofiber size for both type 2A and type 2B fibers in the STZ diabetic mouse.
CONCLUSION: The degeneration and necrosis of myofibers concomitant with the sever atrophy of both the type 2A and 2B myofibers in the STZ muscle could account for the functional alterations seen in diabetic muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037375     DOI: 10.1002/ar.1092390104

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  9 in total

1.  The effects of aerobic exercise on skeletal muscle metabolism, morphology and in situ endurance in diabetic rats.

Authors:  Nilay Ergen; Hatice Kurdak; Seref Erdogan; Ufuk Ozgü Mete; Mehmet Kaya; Nurten Dikmen; Ayşe Doğan; Sanli Sadi Kurdak
Journal:  J Sports Sci Med       Date:  2005-12-01       Impact factor: 2.988

2.  Voluntary physical activity and leucine correct impairments in muscle protein synthesis in partially pancreatectomised rats.

Authors:  A S Serino; O A Adegoke; S Zargar; C S Gordon; A A Szigiato; T J Hawke; M C Riddell
Journal:  Diabetologia       Date:  2011-09-10       Impact factor: 10.122

3.  Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

Authors:  Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

4.  Responses of mouse fast and slow skeletal muscle to streptozotocin diabetes: myosin isoenzymes and phosphorous metabolites.

Authors:  J G Fewell; T S Moerland
Journal:  Mol Cell Biochem       Date:  1995-07-19       Impact factor: 3.396

5.  Role of Ca2+, membrane excitability, and Ca2+ stores in failing muscle contraction with aging.

Authors:  Anthony Michael Payne; Ramón Jimenez-Moreno; Zhong-Ming Wang; María Laura Messi; Osvaldo Delbono
Journal:  Exp Gerontol       Date:  2008-10-10       Impact factor: 4.032

6.  Streptozotocin-induced type 1 diabetes mellitus alters the morphology, secretory function and acyl lipid contents in the isolated rat parotid salivary gland.

Authors:  S Mahay; E Adeghate; M Z Lindley; C E Rolph; J Singh
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

7.  Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats.

Authors:  Célia M C Strunz; Monique Matsuda; Vera M C Salemi; Adriana Nogueira; Antonio P Mansur; Ismar N Cestari; Monica V Marquezini
Journal:  Cardiovasc Diabetol       Date:  2011-04-25       Impact factor: 9.951

8.  Identification of a novel modulator of thyroid hormone receptor-mediated action.

Authors:  Bernhard G Baumgartner; Meritxell Orpinell; Jordi Duran; Vicent Ribas; Hans E Burghardt; Daniel Bach; Ana Victoria Villar; José C Paz; Meritxell González; Marta Camps; Josep Oriola; Francisca Rivera; Manuel Palacín; Antonio Zorzano
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

9.  Myostatin inhibition therapy for insulin-deficient type 1 diabetes.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Namita Deodhare; Eric M Desjardins; Thomas J Hawke
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.